Navitor Pharmaceuticals Funding: $103M Raised

Navitor Pharmaceuticals funding overview

Navitor Pharmaceuticals is based in Cambridge. Navitor Pharmaceuticals has raised $103M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Investors on record include SR One Capital Management, Brace Pharma, Sanofi-Genzyme BioVentures, Johnson & Johnson Development Corporation, Polaris Partners, Atlas Venture and 2 others. 8 distinct backers are named across the disclosed rounds.

Navitor Pharmaceuticals at a glance

Total raised: $103M
Headquarters: Cambridge
Notable investors: SR One Capital Management, Brace Pharma, Sanofi-Genzyme BioVentures, Johnson & Johnson Development Corporation, Polaris Partners, Atlas Venture, Remeditex Ventures, Longevity Fund

Frequently asked about Navitor Pharmaceuticals funding

How much has Navitor Pharmaceuticals raised?: Navitor Pharmaceuticals has raised $103M in total disclosed funding across the rounds on record.
Who has invested in Navitor Pharmaceuticals?: SR One Capital Management, Brace Pharma, Sanofi-Genzyme BioVentures, Johnson & Johnson Development Corporation, Polaris Partners, Atlas Venture are named among the investors backing Navitor Pharmaceuticals.
What was the latest Navitor Pharmaceuticals funding round?: No round stage has been disclosed for Navitor Pharmaceuticals.
Where is Navitor Pharmaceuticals based?: Navitor Pharmaceuticals is based in Cambridge.

Navitor Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.

Navitor Pharmaceuticals Funding: $103M Raised

Navitor Pharmaceuticals funding overview

Navitor Pharmaceuticals at a glance

Frequently asked about Navitor Pharmaceuticals funding

Companies related to Navitor Pharmaceuticals (21)

Browse related funding lists (5)